Dynamic psychological vulnerability and adaptation in rheumatoid arthritis: Trajectories, predictors, and interventions

Figure 3 Pain neurobiology and psychological vulnerability in rheumatoid arthritis. This diagram maps the molecular mechanisms underlying the pain-psychology relationship in rheumatoid arthritis patients, showing how brain structural changes (8%-15% reduced gray matter volume in pain-processing regions) interact with genetic factors (COMT Val158Met polymorphism), neuroplasticity alterations (nerve growth factor/brain-derived neurotrophic factor imbalance), and neuroinflammation pathways to create a 44% reduction in key emotional regulation circuits. The resulting pain-inflammation-emotion cycle helps explain the significant discrepancy between physical and psychological treatment outcomes, where 85% improvement in pain intensity translates to only 42% improvement in mental health, highlighting the necessity for integrated treatment approaches targeting both pain and psychological vulnerability. RA: Rheumatoid arthritis; ACC: Anterior cingulate cortex; NGF: Nerve growth factor; BDNF: Brain-derived neurotrophic factor; TrkA: Tropomyosin receptor kinase A; TrkB: Tropomyosin receptor kinase B; AUC: Area under the curve; GFAP: Glial fibrillary acidic protein; NK1: Neurokinin-1.